Search bioRxiv⌕ Search

Biology subjects

Marino-Ramirez, L.

Publications and source records attributed to Marino-Ramirez, L..

5 recordsLinked to original sources

The Consortium for Genomic Diversity, Ancestry, and Health in Colombia (CODIGO): building local capacity in genomics, bioinformatics, and precision medicine

The Consortium for Genomic Diversity, Ancestry, and Health in Colombia (CODIGO) aims to build a community of Colombian researchers in support of local capacity in genomics, bioinformatics, and precision health. Here, we present the first CODIGO data release and the consortium web platform, including annotations for more than 95 million genetic variants from 1,441 samples representing 14 populations from across the country. CODIGO samples show a wide range of African (16.7%), European (50.6%), and Indigenous American (32.8%) genetic ancestry components, with five distinct ancestry clusters. Thousands of ancestry-enriched variants, with divergent allele frequencies across clusters, show pharmacogenomic and clinical genetic associations. Examples include African ancestry-enriched variants associated with fast metabolism of the immunosuppressive drug tacrolimus and malaria resistance and European ancestry-enriched variants associated with nicotine dependence and hereditary hemochromatosis. CODIGO reveals the nexus between ancestry and health in Colombia and underscores the utility of collaborative genome sequence analysis efforts.

genomics↗

Explainable machine learning for health disparities: type 2 diabetes in the All of Us research program

Type 2 diabetes (T2D) is a disease with high morbidity and mortality and a disproportionate impact on minority groups. Machine learning (ML) is increasingly used to characterize T2D risk factors; however, it has not been used to study T2D health disparities. Our objective was to use explainable ML methods to discover and characterize T2D health disparity risk factors. We applied SHapley Additive exPlanations (SHAP), a new class of explainable ML methods that provide interpretability to ML classifiers, to this end. ML classifiers were used to model T2D risk within and between self-identified race and ethnicity (SIRE) groups, and SHAP values were calculated to quantify the effect of T2D risk factors. We then stratified SHAP values by SIRE to quantify the effect of T2D risk factors on prevalence differences between groups. We found that ML classifiers (random forest, lightGBM, and XGBoost) accurately modeled T2D risk and recaptured the observed prevalence differences between SIRE groups. SHAP analysis showed the top seven most important T2D risk factors for all SIRE groups were the same, with the order of importance for features differing between groups. SHAP values stratified by SIRE showed that income, waist circumference, and education best explain the higher prevalence of T2D in the Black or African American group, compared to the White group, whereas income, education and triglycerides best explain the higher prevalence of T2D in the Hispanic or Latino group. This study demonstrates that explainable ML can be used to elucidate health disparity risk factors and quantify their group-specific effects. Author SummaryWhile machine learning (ML) methods hold great promise for epidemiological studies, their practical utility is limited by interpretability. Increasingly complex ML models are great at predicting disease risk, but how they arrive at a given prediction is often obscured by model complexity. Explainable ML is an emerging discipline that seeks to render ML models more transparent by elucidating how and why input features contribute to output predictions. This study reports a novel application of explainable ML to epidemiology, focusing on type 2 diabetes (T2D) as a paradigm of health disparities. We found that ML classifiers were able to accurately model T2D disparities, for a large cohort of Black, Hispanic, and White Americans, and explainable ML revealed which risk factors contributed to the observed disparities and how. The results demonstrate that explainable ML can be a powerful tool for the discovery and characterization of health disparity risk factors.

bioinformatics↗

Genetic ancestry and population structure in the All of Us Research Program cohort

The NIH All of Us Research Program (All of Us) aims to build one of the worlds most diverse population biomedical datasets in support of equitable precision medicine. For this study, we analyzed participant genomic variant data to assess the extent of population structure and to characterize patterns of genetic ancestry for the All of Us cohort (n=297,549). Unsupervised clustering of genomic principal component analysis (PCA) data revealed a non-uniform distribution of genetic diversity and substantial population structure in the All of Us cohort, with dense clusters of closely related participants interspersed among less dense regions of genomic PC space. Supervised genetic ancestry inference was performed using genetic similarity between All of Us participants and global reference population samples. Participants show diverse genetic ancestry, with major contributions from European (66.4%), African (19.5%), Asian (7.6%), and American (6.3%) continental ancestry components. Participant genetic similarity clusters show group-specific genetic ancestry patterns, with distinct patterns of continental and subcontinental ancestry among groups. We also explored how genetic ancestry changes over space and time in the United States (US). African and American ancestry are enriched in the southeast and southwest regions of the country, respectively, whereas European ancestry is more evenly distributed across the US. The diversity of All of Us participants genetic ancestry is negatively correlated with age; younger participants show higher levels of genetic admixture compared to older participants. Our results underscore the ancestral genetic diversity of the All of Us cohort, a crucial prerequisite for genomic health equity.

bioinformatics↗

Rye: genetic ancestry inference at biobank scale

Biobank projects around the world are generating genomic data for many thousands and even millions of individuals. Computational methods are needed to handle these massive data sets, including tools for genetic ancestry (GA) inference. Current methods for GA inference are generally accurate, but they are slow and do not scale to biobank-size genomic datasets. Here we present Rye - a new algorithm for GA inference at biobank scale. We compare the accuracy and runtime performance of Rye to the widely used RFMix and ADMIXTURE programs, and we apply it to a dataset of 488,221 genome-wide variant samples from the UK Biobank. Rye infers GA based on principal component analysis (PCA) of genomic variant samples from ancestral reference populations and query individuals. The algorithms accuracy is powered by Metropolis-Hastings optimization and its speed is provided by non-negative least squares (NNLS) regression. Rye produces highly accurate GA estimates for three-way admixed populations - African, European, and Native American - compared to RFMix and ADMIXTURE (R2 = 0.998 - 1.00), and shows 50x runtime improvement compared to ADMIXTURE on the UK Biobank dataset. Rye analysis of UK Biobank samples demonstrates how it can be used to infer GA at different levels of relatedness. We discuss user consideration and options for the use of Rye; the program and its documentation are distributed on the GitHub repository: https://github.com/healthdisparities/rye.

bioinformatics↗

BAMscale: quantification of DNA sequencing peaks and generation of scaled coverage tracks

BAMscale is a one-step tool that processes DNA sequencing datasets from chromatin binding (ChIP-seq) and chromatin state changes (ATAC-seq, END-seq) experiments to DNA replication data (OK-seq, NS-seq and replication timing). The outputs include normalized peak scores in text format and scaled coverage tracks (BigWig) which are directly accessible to data visualization programs. BAMscale (available at https://github.com/ncbi/BAMscale) effectively processes large sequencing datasets (~100Gb size) in minutes, outperforming currently available tools.

bioinformatics↗